SHAREHOLDER ALERT: WeissLaw LLP Reminds BSCA, MLND, COHR, and MSGN Shareholders About Its Ongoing Investigations

NEW YORK, May 11, 2021 /PRNewswire/ --

If you own shares in any of the companies listed above and

would like to discuss our investigations or have any questions concerning

this notice or your rights or interests, please contact:

Joshua Rubin, Esq.

WeissLaw LLP

1500 Broadway, 16^th Floor

New York, NY  10036

(212) 682-3025

(888) 593-4771

stockinfo@weisslawllp.com

Bank of Santa Clarita BSCA

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Bank of Santa Clarita BSCA in connection with the proposed acquisition of the company by Southern California Bancorp ("BCAL"). Under the terms of the merger agreement, BSCA shareholders will receive 1.00 share of BCAL common stock for each BSCA share that they own, representing implied per-share merger consideration of approximately $13.50 based upon BCAL's May 10, 2021 closing price of $13.50. If you own BSCA shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/bsca/

Millendo Therapeutics, Inc. MLND

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Millendo Therapeutics, Inc. MLND in connection with the proposed merger of the company with privately-held clinical-stage oncology company Tempest Therapeutics, Inc. Under the terms of the merger agreement, the two companies will combine their businesses in an all-stock transaction that will result in one combined entity that will trade publicly on the Nasdaq Capital Market. If you own MLND shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/mlnd/

Coherent, Inc. COHR

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Coherent, Inc. COHR in connection with the proposed acquisition of the company by II-VI Incorporated ("II-VI"). Under the terms of the agreement, COHR shareholders will receive $220.00 in cash and 0.91 shares of II-VI common stock for each COHR share that they own, representing implied consideration of approximately $276.43 based upon II-VI's May 10, 2021 closing price of $62.01. If you own COHR shares and wish to discuss this investigation or your rights, please call us or visit our website: http://www.weisslawllp.com/cohr/